Certara (CERT) Projected to Post Quarterly Earnings on Thursday

Certara (NASDAQ:CERT) is projected to announce its earnings results after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of $0.12 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Certara Stock Down 0.4 %

Shares of NASDAQ CERT opened at $12.33 on Thursday. Certara has a 52-week low of $9.41 and a 52-week high of $19.87. The company’s 50 day moving average price is $12.39 and its 200-day moving average price is $11.63. The company has a market capitalization of $1.98 billion, a P/E ratio of -61.65, a price-to-earnings-growth ratio of 9.29 and a beta of 1.57. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CERT shares. Robert W. Baird dropped their price objective on Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Barclays lowered their target price on shares of Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a report on Thursday, November 7th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $15.30.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.